Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.

David A. Larson; Jeffrey M. Suplica; Susan M. Chang; Kathleen R. Lamborn; Michael W. McDermott; Penny K. Sneed; Michael D. Prados; William M. Wara; M. Kelly Nicholas; Mitchel S. Berger

doi:10.1215/S1152851703000425

Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.

David A. Larson, Jeffrey M. Suplica, Susan M. Chang, Kathleen R. Lamborn, Michael W. McDermott, Penny K. Sneed, Michael D. Prados, William M. Wara, M. Kelly Nicholas, Mitchel S. Berger

Miami Neuroscience Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	6
DOIs	https://doi.org/10.1215/S1152851703000425
State	Published - Apr 1 2004

Disciplines

Medicine and Health Sciences
Surgery
Other Medical Specialties

Access to Document

10.1215/S1152851703000425License: Unspecified

Cite this

@article{dd96f56fe6f44e3a83f1fbc0af826297,

title = "Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.",

author = "Larson, \{David A.\} and Suplica, \{Jeffrey M.\} and Chang, \{Susan M.\} and Lamborn, \{Kathleen R.\} and McDermott, \{Michael W.\} and Sneed, \{Penny K.\} and Prados, \{Michael D.\} and Wara, \{William M.\} and Nicholas, \{M. Kelly\} and Berger, \{Mitchel S.\}",

note = "This study reports the initial experience at the University of California San Francisco (UCSF) with tumor resection and permanent, low-activity iodine 125 ( 125I) brachytherapy in patients with progressive or recurrent glioblastoma multiforme (GM) and compares these results to those of similar patients treated previously at UCSF with temporary brachytherapy without tumor resection.",

year = "2004",

month = apr,

day = "1",

doi = "10.1215/S1152851703000425",

language = "American English",

volume = "6",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.

AU - Larson, David A.

AU - Suplica, Jeffrey M.

AU - Chang, Susan M.

AU - Lamborn, Kathleen R.

AU - McDermott, Michael W.

AU - Sneed, Penny K.

AU - Prados, Michael D.

AU - Wara, William M.

AU - Nicholas, M. Kelly

AU - Berger, Mitchel S.

N1 - This study reports the initial experience at the University of California San Francisco (UCSF) with tumor resection and permanent, low-activity iodine 125 ( 125I) brachytherapy in patients with progressive or recurrent glioblastoma multiforme (GM) and compares these results to those of similar patients treated previously at UCSF with temporary brachytherapy without tumor resection.

PY - 2004/4/1

Y1 - 2004/4/1

UR - http://europepmc.org/articles/PMC1871978

U2 - 10.1215/S1152851703000425

DO - 10.1215/S1152851703000425

M3 - Article

VL - 6

JO - Neuro-oncology

JF - Neuro-oncology

ER -

Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.

Disciplines

Access to Document

Other files and links

Cite this